Showing results (101-110 of 4,416) with videos related to

Sort By:
Pageof 442
Critical Reviews in Oncology/Hematology|November 19, 2018
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trialsMattia D'Agostino, Lorenzo De Paoli, Concetta Conticello, et al.
Critical Reviews in Oncology/Hematology|January 22, 2021
Relationship between cytokines and symptoms in people with incurable cancer: A systematic reviewRebekah Patton, D Robert Paval, James J McDonald, et al.
Critical Reviews in Oncology/Hematology|January 22, 2021
Will advanced cholangiocarcinoma become a targetable malignancy?Yara Sarkis, Amine Al Soueidy, Hampig Raphael Kourie
Critical Reviews in Oncology/Hematology|January 22, 2021
Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapyMichael I Koukourakis, Alexandra Giatromanolaki
Critical Reviews in Oncology/Hematology|March 6, 2017
Pembrolizumab's non-cross resistance mechanism of action successfully overthrown ipilimumabMohd Wahid, Naseem Akhter, Arshad Jawed, et al.
Critical Reviews in Oncology/Hematology|March 6, 2017
Proton Pump Inhibitors in cancer patients: How useful they are? A review of the most common indications for their useGianmauro Numico, Vittorio Fusco, Pierfrancesco Franco, et al.
Critical Reviews in Oncology/Hematology|March 6, 2017
Epigenetic control of gene expression: Potential implications for cancer treatmentF Perri, F Longo, M Giuliano, et al.
Critical Reviews in Oncology/Hematology|March 6, 2017
Risk assessment in paediatric glioma-Time to move on from the binary classificationA J Dodgshun, J R Hansford, M J Sullivan
Critical Reviews in Oncology/Hematology|March 6, 2017
Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patientsM Mehta, P Wen, R Nishikawa, et al.
Critical Reviews in Oncology/Hematology|March 6, 2017
The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targetingNicolas Jonckheere, Romain Vasseur, Isabelle Van Seuningen
Pageof 442